Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Neuroendocrine Neoplasm”

1,873 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,873 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04792073
What this trial is testing

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT04375527
What this trial is testing

Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC V8Clinical Stage IV Cutaneous Melanoma AJCC V8Locally Advanced Cutaneous Melanoma+8 more
Jonsson Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00005961
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT01565837
What this trial is testing

Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma

Who this might be right for
Melanoma
Wolfram Samlowski 50
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT04318561
What this trial is testing

Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 40
Not applicableLooking for participantsNCT07564570
What this trial is testing

Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

Who this might be right for
Metastatic Melanoma
Universitätsklinikum Hamburg-Eppendorf 40
Testing effectiveness (Phase 2)Study completedNCT00004922
What this trial is testing

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Carcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60
Early research (Phase 1)Study completedNCT01665183
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Who this might be right for
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Polaris Group 8
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01469572
What this trial is testing

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Who this might be right for
Neuroendocrine Tumors
Emory University 13
Not applicableEnded earlyNCT00991991
What this trial is testing

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Case Comprehensive Cancer Center 5
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Not applicableUnknownNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Not applicableUnknownNCT05641012
What this trial is testing

Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Institut Jean-Godinot 100
Not applicableUnknownNCT03593577
What this trial is testing

Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI

Who this might be right for
Vestibular Schwannoma
University Hospital, Strasbourg, France 185
Next Page